US2760978A - Dibenzyl-bis-ammonium salts - Google Patents

Dibenzyl-bis-ammonium salts Download PDF

Info

Publication number
US2760978A
US2760978A US291297A US29129752A US2760978A US 2760978 A US2760978 A US 2760978A US 291297 A US291297 A US 291297A US 29129752 A US29129752 A US 29129752A US 2760978 A US2760978 A US 2760978A
Authority
US
United States
Prior art keywords
dibenzyl
parts
bis
iodide
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US291297A
Inventor
Charles F Huebner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CIBA PHARM PROD Inc
CIBA PHARMACEUTICAL PRODUCTS Inc
Original Assignee
CIBA PHARM PROD Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CIBA PHARM PROD Inc filed Critical CIBA PHARM PROD Inc
Priority to US291297A priority Critical patent/US2760978A/en
Application granted granted Critical
Publication of US2760978A publication Critical patent/US2760978A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D245/00Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/02Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings

Definitions

  • This invention relates to new aryl quaternary ammonium salts.
  • a primary object of the invention is the embodiment of a new group of compounds characterized by a potent curare-like activity and by freedom from undesired side efiects such as hypotension, respiratory paralysis, bronchiospasm, salivation, etc.
  • R stands for a lower alkyl group, such as methyl, ethyl, propyl, butyl, etc.
  • R stands for a lower alkyl group (which may be the same as or difierent from the lower alkyl group represented by R) or for an aralkyl radical, such as benzyl, alkylated benzyl, alkoxylated benzyl, halogenated benzyl, etc.
  • X stands for a halogen atom as for example, a chlorine, bromine or iodine atom.
  • These compounds fulfill the aforementioned desiderata in that, in addition to a high curarelike activity, they do not cause the aforesaid undesired side effects.
  • the compounds are thus useful therapeutically, and may be administered intramuscularly, intravenously or orally.
  • the activity by oral administration is of great importance for the treatment of Parkinsons disease to reduce muscle tremors.
  • the compounds of the invention are prepared by refiuxing for example a 4,4'-diamino-dibenzyl in solution with anexcess of an alkylating agent such as an alkyl halide or a dialkyl sulfate together with an alkali metal hydroxide such as sodium hydroxide or potassium hydroxide, according-in the case of 4,4'-diarnino-dibenzyl itself to the following reaction scheme:
  • the alkylating agent is methyl iodide
  • the product, dibenzyl-4,4-bis-trimethylammonium iodide crystallizes from the reaction mixture.
  • the "alkylating agent is an alkyl halide containing two or more carbon atoms
  • the quaternary ammonium compounds (III) when iubjected to heat, lose alkyl halide to form the bis-tertiary amino dibenzyl derivative which then may be quaternized using the same or a different alkylating agent or an aralkylating agent to produce the quaternary compounds (IV).
  • the iodide salt may be converted to the bromide or the chloride salt by treating the quaternary iodide with silver bromide or silver chloride respectively.
  • alkyl and aralkyl halides examples include methyl iodide, ethyl iodide, propyl iodide, benzyl bromide, ethyl bromide, ethyl chloride, p-methoxybenzyl bromide, p-methylbenzyl bromide and the like.
  • 4,4'-diamino-dibenzyl is alkylated by heating under pressure with an alcohol at a temperature of 200 C.
  • diamino-dibenzyl may be alkylated with ethyl alcohol, propyl alcohol, and the like.
  • Example I 25 parts by weight of 4,4-diamino-dibenzyl are refluxed in 300 parts by volume ethanol with 33 parts by weight of sodium hydroxide and parts by volume of methyl iodide. After six hours of refluxing, during which time the crystalline product slowly separates, the reaction is complete. The crystalline material is separated and, by recrystallization from hot water, yields dibenzyl- 4,4'-bis-(trimethylammonium iodide) H3O CH2 HsC NCH2CH2-@-NClis HaC i i. CH: which melts at 235240 (with decomposition).
  • Example 2 10 parts by weight of dibenzyl-4,4-(trimethylammonium iodide) are heated at 250 under 15 min. pressure for /2 hour. The residue is extracted with benzene, and the benzene extracted with aqueous hydrochloric acid. On making the latter extract alkaline with ammonia, 4,4'bis-(dimethylamino)-dibenzyl separates. The product, which corresponds to the formula H3O CH3 H30 CH3 melts at 152-156", after crystallization from ethanol. By reaction with methyl iodide in alcohol solution, this amine can be converted into dibenzyl-4,4'-bis-(trimethylammonium iodide).
  • Example 5 By substituting 6 parts by volume of propyl iodide for the ethyl iodide employed in Example 4 and otherwise proceeding as described in the latter, there is obtained dibenzyl 4,4 bis (dimethylpropylammonium iodide) which melts at l93197 (with decomposition).
  • Example 6 H3O Bl Br CH; which melts at 150-153 (with decomposition).
  • Example 7 20 parts by weight of 4,4-diamino-dibenzyl are refiuxed for 12 hours with 31 parts by volume of ethyl iodide and 15.2 parts by weight of sodium hydroxide in 300 parts by volume of ethanol. The solution is concentrated to a small volume, the formed sodium iodide is filtered off, and water added to the filtrate. An oil precipitates, which crystallizes on standing. It is recrystallized from methanol to yield 4,4-bis-(diethylamino)-dibenzyl, melting at -83".
  • the mixture is concentrated to a small volume, the sodium iodide which crystallizes is removed by filtration, and water is added to the filtrate.
  • the gummy material which precipitates is shaken with an excess of freshly-prepared silver chloride (about parts by weight) in about 500 parts by volume of water.
  • the silver salts are filtered off, and the aqueous portion evaporated to dryness in vacuo.
  • the solid residue is extracted with a minimum quantity of hot ethyl alcohol, and any sodium chloride which remains undissolved is filtered otf.
  • Ethyl acetate is added to the filtrate until turbidity sets in and, on cooling, crystalline dibenzy1-4,4'-bis-(triethylammonium chloride), melting at 216-221 with decomposition, is obtained.
  • Example 9 5 parts by weight of 4,4T-bis-(dimethylamino)-dibenzyl and 6.9 parts by weight of p-methylbenzyl bromide are refluxed for /2 hour in 20 parts by volume of acetone. The oil which separates is recrystallized from ethanolethyl acetate to yield dibenzyl-4,4-bis-(dimethyl-pmethylbenzyl-ammonium bromide); melting point 194- 198 (decomposition).
  • Example 10 5 parts by weight of 4,4-bis-(dimethylamino)-dibenzyl and 8.1 parts by weight of p-nitrobenzyl bromide are dissolved in 20 parts by volume of dry acetone and allowed to stand overnight at room temperature (e. g. 20 to 30). An oil gradually precipitates which is recrystallized from ethanol-ethyl acetate to yield dibenzyl- 4,4 bis (dimethyl p nitrobenzyl ammonium bromide); melting point -143 (decomposition).
  • Example 11 5 parts by weight of 4,4-bis-(dimethylamino)-dibenzyl and 6 parts by'weight of p-chlorobenzyl chloride are refluxed for 5 minutes in 25 parts by volume of ethanol. Ethyl acetate is added until a cloudiness appears. The small amount of gum which precipitates is separated and on further standing the desired crystalline quaternary compound, dibenzyl 4,4 bis (dimethyl p chlorobenzyl ammonium chloride) is obtained; melting point 123-126.
  • Example 12 2 parts by weight of 4,4-bis-(dimethylamino).-dibenzyl and 3 parts by weight of p-methoxybenzyl bromide are refluxed for 5 minutes in 25 parts by volume of ethanol. Ethyl acetate is added to precipitate the oily product which is redissolved in ethanol and reprecipitated with ethyl acetate to free the preparation from unreacted starting material. The oil is dried in vacuo to yield dibenzyl- 4,4-bis-(dimethyl-p-methoxybenzyl-ammonium bromide) in a resinous state. By dissolving in water, a solution is obtained which is suitable for therapeutic purposes. By dissolving in water and adding an aqueous solution of picrylsulfonic acid, there is obtained the dipicrylsulfonate salt; melting point (decomposition).

Description

United States Patent DIBENZYL-BIS-AMlVlONIUM SALTS No Drawing. Application June 2, 1952, Serial No. 291,297
1 Claim. (Cl. 260567.6)
This invention relates to new aryl quaternary ammonium salts.
A primary object of the invention is the embodiment of a new group of compounds characterized by a potent curare-like activity and by freedom from undesired side efiects such as hypotension, respiratory paralysis, bronchiospasm, salivation, etc.
This object is realized, according to the present invention, by a new group of aryl quaternary amines which correspond to the formula wherein R stands for a lower alkyl group, such as methyl, ethyl, propyl, butyl, etc., R stands for a lower alkyl group (which may be the same as or difierent from the lower alkyl group represented by R) or for an aralkyl radical, such as benzyl, alkylated benzyl, alkoxylated benzyl, halogenated benzyl, etc., and X stands for a halogen atom as for example, a chlorine, bromine or iodine atom. These compounds fulfill the aforementioned desiderata in that, in addition to a high curarelike activity, they do not cause the aforesaid undesired side effects. The compounds are thus useful therapeutically, and may be administered intramuscularly, intravenously or orally. The activity by oral administration is of great importance for the treatment of Parkinsons disease to reduce muscle tremors.
The compounds of the invention are prepared by refiuxing for example a 4,4'-diamino-dibenzyl in solution with anexcess of an alkylating agent such as an alkyl halide or a dialkyl sulfate together with an alkali metal hydroxide such as sodium hydroxide or potassium hydroxide, according-in the case of 4,4'-diarnino-dibenzyl itself to the following reaction scheme:
CH2- NHz GH2- I (R RX X R (III) MOH /R I V RX X R i MOQX heatl {RX V) wherein R, R and X have the previously indicated significances and M stands for an alkali metal.
When the alkylating agent is methyl iodide, the product, dibenzyl-4,4-bis-trimethylammonium iodide crystallizes from the reaction mixture. .When the "alkylating agent is an alkyl halide containing two or more carbon atoms, it is possible to stop the alkylating process at the tertiary amine stage (II) and then to complete quaterna- \ion in an additional step wherein if desired another lkylating agent is employed.
The quaternary ammonium compounds (III), when iubjected to heat, lose alkyl halide to form the bis-tertiary amino dibenzyl derivative which then may be quaternized using the same or a different alkylating agent or an aralkylating agent to produce the quaternary compounds (IV).
The iodide salt may be converted to the bromide or the chloride salt by treating the quaternary iodide with silver bromide or silver chloride respectively.
Examples of suitable alkyl and aralkyl halides are methyl iodide, ethyl iodide, propyl iodide, benzyl bromide, ethyl bromide, ethyl chloride, p-methoxybenzyl bromide, p-methylbenzyl bromide and the like.
Alternatively, 4,4'-diamino-dibenzyl is alkylated by heating under pressure with an alcohol at a temperature of 200 C. In this way diamino-dibenzyl may be alkylated with ethyl alcohol, propyl alcohol, and the like.
The following examples set forth representative exemplary embodiments of the invention, and these examples are intended to be illustrative and not limitative. In these examples, parts by weight bear the same relation as to parts by volume as does the kilogram to the liter. Temperatures are expressed in degrees centigrade. Percentages are by weight. All melting points are uncorrected.
Example I 25 parts by weight of 4,4-diamino-dibenzyl are refluxed in 300 parts by volume ethanol with 33 parts by weight of sodium hydroxide and parts by volume of methyl iodide. After six hours of refluxing, during which time the crystalline product slowly separates, the reaction is complete. The crystalline material is separated and, by recrystallization from hot water, yields dibenzyl- 4,4'-bis-(trimethylammonium iodide) H3O CH2 HsC NCH2CH2-@-NClis HaC i i. CH: which melts at 235240 (with decomposition).
Example 2 Example 3 10 parts by weight of dibenzyl-4,4-(trimethylammonium iodide) are heated at 250 under 15 min. pressure for /2 hour. The residue is extracted with benzene, and the benzene extracted with aqueous hydrochloric acid. On making the latter extract alkaline with ammonia, 4,4'bis-(dimethylamino)-dibenzyl separates. The product, which corresponds to the formula H3O CH3 H30 CH3 melts at 152-156", after crystallization from ethanol. By reaction with methyl iodide in alcohol solution, this amine can be converted into dibenzyl-4,4'-bis-(trimethylammonium iodide).
Ex m l 4 1 5 parts of 4,4-bis-(dimethylamino)-dibenzyl are re uxe .Qvernight with 6 P r b q um .of th l d de in 50 parts by volume of ethanol-benzenemixture (:1).
Ethyl acetate is added to complete the erystallization of the quaternary salt. It is recrystallized from 95% ethanol, yielding dibenzyl-4,4 -bis-.(dimethylethylammonium iodide) H: 1 I C2135 Whieh melts at 2l3-217 (with decomposition).
Example 5 By substituting 6 parts by volume of propyl iodide for the ethyl iodide employed in Example 4 and otherwise proceeding as described in the latter, there is obtained dibenzyl 4,4 bis (dimethylpropylammonium iodide) which melts at l93197 (with decomposition).
Example 6 H3O Bl Br CH; which melts at 150-153 (with decomposition).
Example 7 20 parts by weight of 4,4-diamino-dibenzyl are refiuxed for 12 hours with 31 parts by volume of ethyl iodide and 15.2 parts by weight of sodium hydroxide in 300 parts by volume of ethanol. The solution is concentrated to a small volume, the formed sodium iodide is filtered off, and water added to the filtrate. An oil precipitates, which crystallizes on standing. It is recrystallized from methanol to yield 4,4-bis-(diethylamino)-dibenzyl, melting at -83". Reaction with methyl iodide in the manner hereinbefore described yields dibenzyl-4,4'-bis-(diethylmethylammonium iodide) which melts at 225-230 (with decomposition); and reaction with benzyl bromide yields dibenzyl-4,4-bis-(benzyldiethylammonium bromide) which melts at 235-241 (with decomposition) Example 8 20 parts by weight of 4,4-diamino-dibenzyl are refluxed for 12 hours with 20 parts by weight of sodium hydroxide and 60 parts by volume of ethyl iodide in 300 parts by volume .of ethanol. The mixture is concentrated to a small volume, the sodium iodide which crystallizes is removed by filtration, and water is added to the filtrate. The gummy material which precipitates is shaken with an excess of freshly-prepared silver chloride (about parts by weight) in about 500 parts by volume of water. The silver salts are filtered off, and the aqueous portion evaporated to dryness in vacuo. The solid residue is extracted with a minimum quantity of hot ethyl alcohol, and any sodium chloride which remains undissolved is filtered otf. Ethyl acetate is added to the filtrate until turbidity sets in and, on cooling, crystalline dibenzy1-4,4'-bis-(triethylammonium chloride), melting at 216-221 with decomposition, is obtained.
Example 9 5 parts by weight of 4,4T-bis-(dimethylamino)-dibenzyl and 6.9 parts by weight of p-methylbenzyl bromide are refluxed for /2 hour in 20 parts by volume of acetone. The oil which separates is recrystallized from ethanolethyl acetate to yield dibenzyl-4,4-bis-(dimethyl-pmethylbenzyl-ammonium bromide); melting point 194- 198 (decomposition).
Example 10 5 parts by weight of 4,4-bis-(dimethylamino)-dibenzyl and 8.1 parts by weight of p-nitrobenzyl bromide are dissolved in 20 parts by volume of dry acetone and allowed to stand overnight at room temperature (e. g. 20 to 30). An oil gradually precipitates which is recrystallized from ethanol-ethyl acetate to yield dibenzyl- 4,4 bis (dimethyl p nitrobenzyl ammonium bromide); melting point -143 (decomposition).
Example 11 5 parts by weight of 4,4-bis-(dimethylamino)-dibenzyl and 6 parts by'weight of p-chlorobenzyl chloride are refluxed for 5 minutes in 25 parts by volume of ethanol. Ethyl acetate is added until a cloudiness appears. The small amount of gum which precipitates is separated and on further standing the desired crystalline quaternary compound, dibenzyl 4,4 bis (dimethyl p chlorobenzyl ammonium chloride) is obtained; melting point 123-126.
Proceeding similarly using 5.05 parts by volume of m-methylbenzyl bromide instead of the p-chlorobenzyl chloride, there is obtained dibenzyl-4,4',-bis-(dimethylm-methylbenzyl ammonium bromide); melting point 143-146".
Example 12 2 parts by weight of 4,4-bis-(dimethylamino).-dibenzyl and 3 parts by weight of p-methoxybenzyl bromide are refluxed for 5 minutes in 25 parts by volume of ethanol. Ethyl acetate is added to precipitate the oily product which is redissolved in ethanol and reprecipitated with ethyl acetate to free the preparation from unreacted starting material. The oil is dried in vacuo to yield dibenzyl- 4,4-bis-(dimethyl-p-methoxybenzyl-ammonium bromide) in a resinous state. By dissolving in water, a solution is obtained which is suitable for therapeutic purposes. By dissolving in water and adding an aqueous solution of picrylsulfonic acid, there is obtained the dipicrylsulfonate salt; melting point (decomposition).
Having thus disclosed the invention, What is claimed is:
Dibenzyl-4,4-bis-(triethylammonium chloride) References Cited in the file of this patent UNITED STATES PATENTS Crossley Dec. 30, 1952 OTHER REFERENCES IIegmann et al.: Ber. deut. chem, vol. 20 (1887), p.
US291297A 1952-06-02 1952-06-02 Dibenzyl-bis-ammonium salts Expired - Lifetime US2760978A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US291297A US2760978A (en) 1952-06-02 1952-06-02 Dibenzyl-bis-ammonium salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US291297A US2760978A (en) 1952-06-02 1952-06-02 Dibenzyl-bis-ammonium salts

Publications (1)

Publication Number Publication Date
US2760978A true US2760978A (en) 1956-08-28

Family

ID=23119738

Family Applications (1)

Application Number Title Priority Date Filing Date
US291297A Expired - Lifetime US2760978A (en) 1952-06-02 1952-06-02 Dibenzyl-bis-ammonium salts

Country Status (1)

Country Link
US (1) US2760978A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2914562A (en) * 1957-08-06 1959-11-24 Wm S Merrell Co Amine derivatives of triphenylethanol
US2967755A (en) * 1957-02-05 1961-01-10 Sandoz Ltd Leveling and stripping agents
US4137239A (en) * 1976-05-26 1979-01-30 Khromov Borisov Nikolai V p,p"bis-Quaternary ammonium salts of p-terphenyl and method of preparing same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2623902A (en) * 1950-03-15 1952-12-30 Sharp & Dohme Inc Bis-quaternary ammonium salts

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2623902A (en) * 1950-03-15 1952-12-30 Sharp & Dohme Inc Bis-quaternary ammonium salts

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2967755A (en) * 1957-02-05 1961-01-10 Sandoz Ltd Leveling and stripping agents
US2914562A (en) * 1957-08-06 1959-11-24 Wm S Merrell Co Amine derivatives of triphenylethanol
US4137239A (en) * 1976-05-26 1979-01-30 Khromov Borisov Nikolai V p,p"bis-Quaternary ammonium salts of p-terphenyl and method of preparing same

Similar Documents

Publication Publication Date Title
US2590125A (en) Quaternary-ammonium alkyl
KR860002034B1 (en) Process for preparing benzothiazepine derivatives
US2760978A (en) Dibenzyl-bis-ammonium salts
US3575985A (en) Pyridinium compounds
US3634508A (en) Phenylacetylguanidines
US2783230A (en) Derivatives of meta hydroxy aniline
US2974139A (en) Thiophenylpyridyl amines
US2658067A (en) Substituted carbamic acdj esters
US2729645A (en) 1-[2-(dithiocarboxyamino)polymethylene] quaternary ammonium inner salts
US3436391A (en) Dihydroanthracene compounds
JPS63145286A (en) Bicyclic imidazole derivative
JPS5936670A (en) Benzothiazole derivative, its preparation and anorectic agent containing the same
Dains et al. THE REACTIONS OF THE FORMAMIDINES. VIII. SOME THIAZOLIDONE DERIVATIVES.
US4198509A (en) Mercaptoacylpiperazine carboxylic acid compounds
GB2067990A (en) Cinnamyl moranoline derivatives
US3920651A (en) Quaternary ammonium compounds
SU458980A3 (en) Method for producing thiazolquinoline derivatives
US1633392A (en) Sedative and hypnotic ureides
US2820042A (en) 2-(dialkylaminoalkylthio) benzoxazoles and processes for their production
US4118501A (en) Thiazolidine derivatives
US3170910A (en) Cationic azo compounds
JPH0124793B2 (en)
US4156735A (en) Thiazolidine derivatives
GB2053900A (en) 6,8-Dibromo-1,4-dihydro-2H- 3,1-benzoxazine-2-one and the production of bromhexin
DE1795380A1 (en) Pharmaceutical preparations for the treatment of nematode infections